KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2026)

Pacific Biosciences Of California has reported Return on Invested Capital over the past 4 years, most recently at 0.27% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 26.0% year-over-year to 0.27%; the TTM value through Dec 2025 reached 0.27%, down 26.0%, while the annual FY2025 figure was 0.02%, 1.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.27% at Pacific Biosciences Of California, down from 0.14% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q3 2023 and troughed at 0.27% in Q4 2025.
  • A 4-year average of 0.05% and a median of 0.01% in 2024 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2023 and later dropped -26bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.0% in 2022, then rose by 5bps to 0.0% in 2023, then plummeted by -140bps to 0.01% in 2024, then plummeted by -2603bps to 0.27% in 2025.
  • Business Quant data shows Return on Invested Capital for PACB at 0.27% in Q4 2025, 0.14% in Q3 2025, and 0.09% in Q2 2025.